Eventide Asset Management

Eventide Asset Management accounts for 16 tracked companies with verified cap-table data, 16 of which disclose round sizes totalling $3.2B. The median disclosed raise is $196M, and the largest is Talaris Therapeutics at $365M, ahead of Kardium ($340M) and Metagenomi ($300M).

The names that recur most often on these co-invested cap tables are Eventide Asset Management (16 companies), Third Rock Ventures (4 companies), Surveyor Capital (3 companies), Invus (3 companies), Longitude Capital (3 companies), Leaps by Bayer (3 companies). By latest disclosed round, the market skews Series B (6), Series C (4), Other Equity (1), Growth (1).

• Companies tracked: 16
• Disclosed funding total: $3.2B across 16 companies
• Median disclosed raise: $196M
• Largest raise: Talaris Therapeutics — $365M
• Stage mix: Series B 6 · Series C 4 · Other Equity 1 · Growth 1
• Most recent dated round: 2026-06-30

Best funded Eventide Asset Management companies

1. Talaris Therapeutics — $365M (latest: Other Equity)
2. Kardium — $340M (latest: Growth)
3. Metagenomi — $300M (latest: Series B)
4. Flare Therapeutics — $287M (latest: Series C)
5. Spur Therapeutics — $274M
6. Pliant Therapeutics — $251M (latest: IPO)
7. Arch Oncology — $241M (latest: Series C)
8. Kestra Medical Technologies, Inc. — $196M (latest: Series C)
9. Sudo Biosciences — $188M (latest: Series B)
10. LEXEO Therapeutics — $185M (latest: Series B)
11. Goldfinch Biopharma — $160M (latest: Series B)
12. Leo Cancer Care — $150M (latest: Series D)
13. Entasis Therapeutics — $122M (latest: Series B)
14. Mersana Therapeutics — $85M (latest: Series C)
15. Kojin Therapeutics — $60M (latest: Series A)

Eventide Asset Management — related firms and companies (56)

• Talaris Therapeutics
• Kardium
• Metagenomi
• Flare Therapeutics
• Spur Therapeutics
• Pliant Therapeutics
• Arch Oncology
• Kestra Medical Technologies, Inc.
• Investors like Flybridge
• Companies backed by Eventide Asset Management
• Investors like White Star Capital
• Investors like IVP
• LEXEO Therapeutics
• Investors like Andreessen Horowitz
• Investors like Maveron
• Investors like Fika Ventures
• Investors like Bessemer Venture Partners
• Leo Cancer Care
• Investors like GSR Ventures
• Investors like Index Ventures
• Investors like Bain Capital
• Investors like Script Capital
• Mersana Therapeutics
• Investors like General Atlantic
• Investors like CAVU Consumer Partners
• Investors like Oak HC/FT
• Investors like Sapphire Ventures
• PreciseDx
• Investors like Balderton Capital
• Investors like Venrock
• Investors like Great Oaks Venture Capital
• Investors like Sequoia Capital
• Investors like Eventide Asset Management
• Investors like Storm Ventures
• Investors like BoxGroup
• Sudo Biosciences
• Investors like Peak XV Partners
• Investors like First Round Capital
• Investors like Tiger Global Management
• Investors like Alexandria Venture Investments
• Goldfinch Biopharma
• Investors like Headline
• Investors like Shasta Ventures
• Investors like Thirdbase Capital
• Investors like Benchmark
• Entasis Therapeutics
• Investors like Blockchain Capital
• Investors like Floodgate
• Investors like Thrive Capital
• Investors like Founders Fund
• Kojin Therapeutics
• Investors like Emergence Capital
• Investors like SV Angel
• Investors like Matrix
• Investors like Next47
• Eventide Asset Management portfolio companies 2026

Eventide Asset Management alternatives · All research reports